Insights
Articles, regulatory updates, and resources on federal DEA compliance.
Articles
When DEA Registration Collides With State Law
A Mississippi dispensary's pending application shows how 21 CFR 1301.76 and 1301.90 apply to state licensed operators, and why state employment rules do not settle federal eligibility.
Read MoreRegulatory Updates
How State Regulators Are Responding to Medical Cannabis Rescheduling
A state by state summary of rules, bulletins, and positions issued by state cannabis regulators since the April 2026 Final Order.
Read MoreDEA Registration Remains Open After the Expedited Window
The expedition provision in 21 CFR 1301.13(k)(7) has ended. The registration pathway and the public interest standard that governs it remain in place.
Read MoreCalifornia Adopts Emergency Rule Allowing Separate Medicinal Retail Licenses
DCC-2026-03-E lets dual designated retailers split into separate adult use and medicinal licenses to support DEA registration.
Read MoreOklahoma Requires DEA Registration for Medical Marijuana Manufacturers and Distributors
OBNDD will treat DEA registration as a condition of state registration beginning January 1, 2027, while OMMA's rules remain unchanged.
Read MoreFinal Order Places State Licensed Medical Marijuana in Schedule III
What AG Order No. 6754-2026 changed, how 21 CFR 1301.13(k) works, and where the companion hearing and the D.C. Circuit challenge stand.
Read MoreTreasury and IRS Announce Forthcoming Tax Guidance on the Final Order
What Treasury and the IRS said on April 23 about Section 280E, apportionment, and the transition rule, and what remains unpublished.
Read MoreResources
Controlled Substances Act
Title 21, United States Code
- 21 U.S.C. 802DefinitionsView
- 21 U.S.C. 811Authority and criteria for classification of substancesView
- 21 U.S.C. 812Schedules of controlled substancesView
- 21 U.S.C. 822Persons required to registerView
- 21 U.S.C. 823Registration requirementsView
- 21 U.S.C. 824Denial, revocation, or suspension of registrationView
- 21 U.S.C. 827Records and reports of registrantsView
- 21 U.S.C. 880Administrative inspections and warrantsView
- 21 U.S.C. 903Application of State lawView
- 21 U.S.C. 952Importation of controlled substancesView
- 21 U.S.C. 953Exportation of controlled substancesView
DEA Regulations
Title 21, Code of Federal Regulations, Chapter II
- 21 CFR 1300.01Definitions relating to controlled substancesView
- 21 CFR 1301.12Separate registrations for separate locationsView
- 21 CFR 1301.13Application for registration, including paragraph (k), medical marijuana registrationsView
- 21 CFR 1301.31Administrative review generallyView
- 21 CFR 1301.37Order to show causeView
- 21 CFR 1301.43Request for hearing or appearance; waiverView
- 21 CFR 1301.71Security requirements generallyView
- 21 CFR 1301.74Other security controls for non-practitionersView
- 21 CFR 1301.76Other security controls for practitionersView
- 21 CFR 1301.90Employee screening proceduresView
- 21 CFR 1301.91Employee responsibility to report drug diversionView
- 21 CFR 1301.93Sources of information for employee checksView
- 21 CFR Part 1304Records and reports of registrantsView
- 21 CFR 1304.11Inventory requirementsView
- 21 CFR 1308.13Schedule IIIView
- 21 CFR Part 1312Importation and exportation of controlled substancesView
- 21 CFR Part 1316, Subpart AAdministrative inspectionsView
Federal Register and Agency Guidance
Final orders, agency clarifications, and related federal guidance
- 91 FR 22714Final Order rescheduling FDA approved products and state licensed medical marijuana to Schedule III (April 28, 2026)View
- DEA DiversionClarification of 21 CFR 1301.90, employee screening for non-practitionersView
- DEA DiversionDiversion Control Division, registration, forms, and guidanceView
- 26 U.S.C. 280EExpenditures in connection with the illegal sale of drugsView
- 26 U.S.C. 6511Limitations on credit or refundView
- U.S. TreasuryTreasury and IRS announcement on tax guidance following the Final Order (April 23, 2026)View
- UNODCSingle Convention on Narcotic Drugs, 1961, as amendedView
Discuss Your DEA Registration
We advise U.S. state medical cannabis operators on DEA registration, security, and recordkeeping requirements. Contact us to schedule a consultation.
Schedule a Consultation